Webinar | The investor’s role in the fight against AMR: Investing responsibly to maximise impact

Webinar | The investor’s role in the fight against AMR: Investing responsibly to maximise impact

In recognition of the World Antimicrobial Resistance (AMR) Awareness Week 2025, the Access to Medicine Foundation hosted a live webinar in collaboration with the World Health Organization (WHO), to discuss the role investors can play in helping to curb the impact of antimicrobial resistance. The webinar speakers were: - Valeria Gigante, Team Lead, AMR Department, WHO - Jaideep A Gogtay, Global Chief Medical Officer, Cipla - Maria Souza, Senior Impact Analyst, Baillie Gifford - Evelyn Wesangula, Senior AMR Control Specialist, East Central and Southern Africa Health Community (ECSA- HC) The discussion was moderated by Claudia Martínez, the Foundation’s Director of Research. Learn more about the Foundation's AMR Programme 👉 https://accesstomedicinefoundation.org/cross-sector-programmes/antimicrobial-resistance-programme Visit our website 👉 https://accesstomedicinefoundation.org/ Follow us on social media: LinkedIn 👉 https://www.linkedin.com/company/access-to-medicine-foundation/ Bluesky 👉 https://bsky.app/profile/accesstomedicinefoundation.org X 👉 https://twitter.com/atmindex #WAAW #AMR #AntimicrobialResistance #DrugResistance #AccesstoMedicine #AccesstoHealthcare #EquitableAccess #HealthEquity #pharma